A new review sheds light on the complex molecular mechanisms behind Angelman syndrome (AS), a rare neurogenetic disorder, and ...

CBD Life Sciences Inc. (CBDL) has entered the $2.8 billion global suppository market with the launch of its new line of ...

CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Relacorilant combined with nab-paclitaxel (Abraxane) significantly improved progression-free and overall survival in patients with platinum-resistant ovarian cancer in the phase 3 ROSELLA trial, ...

Kisqali plus aromatase inhibitor improved outcomes across age and menopausal status in early hormone receptor–positive, ...

A groundbreaking study has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161 ...

AstraZeneca's camizestrant and Pfizer's vepdegestrant extended progression-free survival in trials in advanced ESR1-mutated breast cancer.

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Radionuclide therapy with the radioactive element terbium could effectively combat lymphoma. This is demonstrated by ...

Radionuclide therapy with the radioactive element terbium could effectively combat lymphoma. This is demonstrated by ...